Tyco/Radionics Seeks Quality System Auditor Following FDA Warning Letter
This article was originally published in The Gray Sheet
Tyco Healthcare Group subsidiary Radionics should stop shipping certain products that FDA believes pose sterility concerns, the agency suggests in a warning letter dated March 8 and released March 26
You may also be interested in...
Baxter has implemented 100% leak testing as part of its efforts to respond to a recent FDA warning letter that detailed quality systems infractions
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.